• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

139
19
13
13
11

COUNTRY

5
4
4
4
3

PRICE

6
93
123
496

PUBLISHED

1
17
126
496

PRODUCT TYPE

488
5
2
1

Immune Disorders

More than 150 primary immunodeficiency diseases (PIDs) have been identified, a number that does not include acquired immunodeficiencies. Examples of immune disorders include Type 1 diabetes, rheumatoid arthritis, allergies, Crohn’s Disease, and HIV, which infects over 0.5% of the world’s population.

In the reports and subscriptions listed under Research and Markets’ category you will find pipeline assessments of drugs and therapeutics, market forecasts, investment and growth opportunities, and much more. Also explored in-depth is the key role of immune response and pharmaceuticals in transplant medicine, with reviews of clinical trials, market trends and major companies in the areas of lung transplants, liver transplants, transplant inflammation/rejection, etc.

Key players profiled include Abbott Laboratories, Pfizer, Johnson & Johnson, Biogen Idec, Amgen, Bayer AG, Sanofi, and more. Show Less
Read more

PRODUCT TITLE

Chediak-Higashi Syndrome Global Clinical Trials Review, H2, 2014

Chediak-Higashi Syndrome Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Chediak-Higashi Syndrome Global Clinical Trials Review, H2, 2014" provides data on the Chediak-Higashi...

October 2014
FROM

Pollen Allergy Global Clinical Trials Review, H2, 2014

Pollen Allergy Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Pollen Allergy Global Clinical Trials Review, H2, 2014" provides data on the Pollen Allergy clinical trial...

October 2014
FROM

X-Linked Agammaglobulinemia Global Clinical Trials Review, H2, 2014

X-Linked Agammaglobulinemia Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “X-Linked Agammaglobulinemia Global Clinical Trials Review, H2, 2014" provides data on the X-Linked...

October 2014
FROM

Churg-Strauss Syndrome Global Clinical Trials Review, H2, 2014

Churg-Strauss Syndrome Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Churg-Strauss Syndrome Global Clinical Trials Review, H2, 2014" provides data on the Churg-Strauss...

October 2014
FROM

Kawasaki Disease Global Clinical Trials Review, H2, 2014

Kawasaki Disease Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Kawasaki Disease Global Clinical Trials Review, H2, 2014" provides data on the Kawasaki Disease clinical...

October 2014
FROM

Mild Psoriasis Global Clinical Trials Review, H2, 2014

Mild Psoriasis Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Mild Psoriasis Global Clinical Trials Review, H2, 2014" provides data on the Mild Psoriasis clinical trial...

October 2014
FROM

Anca Vasculitis Global Clinical Trials Review, H2, 2014

Anca Vasculitis Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Anca Vasculitis Global Clinical Trials Review, H2, 2014" provides data on the Anca Vasculitis clinical trial...

September 2014
FROM

Cat Allergy Global Clinical Trials Review, H2, 2014

Cat Allergy Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Cat Allergy Global Clinical Trials Review, H2, 2014" provides data on the Cat Allergy clinical trial scenario....

September 2014
FROM

Birch Pollen Allergy Global Clinical Trials Review, H2, 2014

Birch Pollen Allergy Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Birch Pollen Allergy Global Clinical Trials Review, H2, 2014" provides data on the Birch Pollen Allergy...

September 2014
FROM

Cedar Pollen Allergy Global Clinical Trials Review, H2, 2014

Cedar Pollen Allergy Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Cedar Pollen Allergy Global Clinical Trials Review, H2, 2014" provides data on the Cedar Pollen Allergy...

September 2014
FROM

Behcet's Disease Global Clinical Trials Review, H2, 2014

Behcet's Disease Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Behcet's Disease Global Clinical Trials Review, H2, 2014" provides data on the Behcet’s Disease clinical...

September 2014
FROM

House Dust Mite Allergy - Pipeline Review, H2 2014

House Dust Mite Allergy - Pipeline Review, H2 2014 Summary This, ‘House Dust Mite Allergy - Pipeline Review, H2 2014’, provides an overview of the House Dust Mite Allergy’s therapeutic pipeline. This...

September 2014
FROM
Competitor Analysis: Rabies Virus Vaccines, Antibodies and Immune Globulins Competitor Analysis: Rabies Virus Vaccines, Antibodies and Immune Globulins - Product Thumbnail Image

Competitor Analysis: Rabies Virus Vaccines, Antibodies and Immune Globulins

The present Competitive Intelligence Report about prophylaxis and therapy of Rabies virus infections provides a competitor evaluation in the field of marketed and new molecules for prevention or treatment...

September 2014
FROM
Immunoassay Systems - Global Strategic Business Report Immunoassay Systems - Global Strategic Business Report - Product Thumbnail Image

Immunoassay Systems - Global Strategic Business Report

This report analyzes the worldwide markets for Immunoassay Systems in US$ Million by the following Product Segments, which includes Immunoassay Analyzers and Reagents: Enzyme Immunoassay Systems, Fluorescence...

September 2014
FROM

OpportunityAnalyzer: Graft-Versus-Host Disease - Opportunity Analysis and Forecasts to 2018

OpportunityAnalyzer: Graft-Versus-Host Disease - Opportunity Analysis and Forecasts to 2018 Summary The main drivers of growth in graft versus host disease over the 2013-2018 forecast period include...

August 2014
FROM

EpiCast Report: Graft-Versus-Host Disease - Epidemiology Forecast to 2023

EpiCast Report: Graft-Versus-Host Disease - Epidemiology Forecast to 2023 Summary Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT)...

July 2014
FROM

Chronic Inflammation - Pipeline Review, H1 2014

Chronic Inflammation - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Chronic Inflammation - Pipeline Review, H1 2014’, provides an overview of the Chronic Inflammation’s therapeutic pipeline. This...

May 2014
FROM

Hereditary Angioedema (HAE) - Pipeline Review, H1 2014

Hereditary Angioedema (HAE) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hereditary Angioedema (HAE) - Pipeline Review, H1 2014’, provides an overview of the Hereditary Angioedema...

May 2014
FROM

Grass Pollen Allergy - Pipeline Review, H1 2014

Grass Pollen Allergy - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Grass Pollen Allergy - Pipeline Review, H1 2014’, provides an overview of the Grass Pollen Allergy’s therapeutic pipeline. This...

May 2014
FROM

Wegener's Granulomatosis - Pipeline Review, H1 2014

Wegener's Granulomatosis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Wegener's Granulomatosis - Pipeline Review, H1 2014’, provides an overview of the Wegener's Granulomatosis’s therapeutic...

May 2014
FROM
Loading Indicator

Our Clients

Merck & Co., Inc. Celgene Corporation GlaxoSmithKline PLC Genentech, Inc. Johnson & Johnson Services, Inc. ViiV Healthcare